Scalp Roller Therapy in Resistant Alopecia Areata

The document reports on three cases of resistant alopecia areata (AA) treated with Scalp Roller therapy, a method that involves creating microchannels in the scalp to facilitate the delivery of a therapeutic mixture. The mixture contained triamcinolone acetonide, a meso-solution with growth factors and other nutrients, and injectable minoxidil. The three patients, who had not responded to previous treatments including contact sensitisers, topical tacrolimus, minoxidil, corticosteroids, and oral mini pulse betamethasone, showed significant improvement after undergoing Scalp Roller therapy. The 11-year-old girl (Case 1) had a 90% improvement after four sessions, the 34-year-old male (Case 2) had a 50% improvement of scalp hair after five sessions, and the 18-year-old male (Case 3) had a 75% improvement in six sessions. No adverse events were reported, and the improvement was localized to the scalp, with no effect on eyebrows or axilla hair. The study suggests that Scalp Roller therapy could be an effective and safe adjunct treatment for resistant AA, but acknowledges that randomized controlled studies are needed to confirm the efficacy of this multimodal approach.